We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISRG:NASDAQIntuitive Surgical, Inc. Analysis

Data as of 2026-05-27 - not real-time

$417.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Intuitive Surgical (ISRG) is trading at $417.95, well under its 20‑day ($441.23), 50‑day ($456.18) and 200‑day ($495.55) moving averages, signaling a bearish short‑term price trend. The RSI of 36 and a bearish MACD histogram (-0.35) further underscore recent momentum weakness, while the 30‑day volatility of 40% and a beta near 0.93 suggest the stock is more volatile than the market. On the valuation side, the trailing P/E of 50.9 dwarfs the industry average of 27.4 and the DCF‑derived fair value of $223.19, indicating the market is pricing in substantial future growth despite current overvaluation.
Fundamentally, ISRG delivers strong financial performance with 23% revenue growth, 66% gross margin and 31% operating margin, supported by $4.5 B of cash and zero debt. Analysts remain optimistic, assigning a “Buy” consensus and a median price target of $578.5, implying roughly 37% upside from today’s price. Recent headlines highlight continued innovation and a perceived bullish upside of ~35%, even as the stock slipped 7.2% post‑earnings, reflecting a mix of growth enthusiasm and short‑term price pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical weakness: price below key moving averages and bearish MACD
  • Near support at $414.30 limiting downside
  • Recent earnings miss causing 7.2% price decline

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 23% revenue growth and high operating margins
  • Strong cash position with no debt
  • Analyst consensus and median target price suggesting ~37% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable competitive moat from the da Vinci platform
  • Expansion into diagnostic endoluminal procedures (Ion system)
  • Long‑term secular demand for minimally invasive surgery

Key Metrics & Analysis

Financial Health

Revenue Growth23.00%
Profit Margin28.15%
P/E Ratio50.9
ROE17.23%
ROA10.24%
P/B Ratio8.5
Op. Cash Flow$3.4B
Free Cash Flow$2.3B
Industry P/E27.4

Technical Analysis

TrendBearish
RSI36.1
Support$414.30
Resistance$463.50
MA 20$441.23
MA 50$456.18
MA 200$495.55
MACDBearish
VolumeStable
Fear & Greed Index91.89

Valuation

Fair Value$223.19
Target Price$572.68
Upside/Downside37.02%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.93
Volatility40.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.